The platelet-derived growth factor system in renal disease: An emerging role of endogenous inhibitors

European Journal of Cell Biology

Volumn 91, Issue 6-7, 2012, Pages 542-551

  van Roeyen, Claudia R C ^a   Ostendorf, Tammo ^a   Floege, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Antagonist; Growth factors; Inhibitors; Renal disease

Indexed keywords

ADIPONECTIN; ALPHA 2 MACROGLOBULIN; BONE MORPHOGENETIC PROTEIN 2; BRADYKININ; BRADYKININ B1 RECEPTOR; LAMININ ALPHA4; LIPOXIN; MATRIPTASE; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION; GLOMERULONEPHRITIS; HUMAN; KIDNEY DISEASE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY;

ANIMALS; HUMANS; KIDNEY DISEASES; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84860229922     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.07.003     Document Type: Short Survey

References (110)

1. Abrass C.K., Hansen K.M., Patton B.L. Laminin alpha4-null mutant mice develop chronic kidney disease with persistent overexpression of platelet-derived growth factor. Am. J. Pathol. 2010, 176:839-849.
2. Akai Y., Iwano M., Kitamura Y., Shiiki H., Dohi Y., Dohi K., Moriyama T., Yonemasu K. Intraglomerular expressions of IL-1 alpha and platelet-derived growth factor (PDGF-B) mRNA in experimental immune complex-mediated glomerulonephritis. Clin. Exp. Immunol. 1994, 95:29-34.
3. Alpers C.E., Hudkins K.L., Ferguson M., Johnson R.J., Rutledge J.C. Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int. 1995, 48:146-154.
4. Alpers C.E., Seifert R.A., Hudkins K.L., Johnson R.J., Bowen-Pope D.F. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int. 1993, 43:286-294.
5. Barnes J.L., Abboud H.E. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis. Am. J. Pathol. 1993, 143:1366-1376.
6. Barnes J.L., Woodruff K.A., Levine S.P., Abboud H.E. Inhibition of mesangial cell proliferation by platelet factor 4. J. Am. Soc. Nephrol. 1996, 7:991-998.
7. Bazenet C.E., Kazlauskas A. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP. Oncogene 1994, 9:517-525.
8. Bergsten E., Uutela M., Li X., Pietras K., Ostman A., Heldin C.H., Alitalo K., Eriksson U. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat. Cell Biol. 2001, 3:512-516.
9. Bjarnegard M., Enge M., Norlin J., Gustafsdottir S., Fredriksson S., Abramsson A., Takemoto M., Gustafsson E., Fassler R., Betsholtz C. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004, 131:1847-1857.
10. Bokemeyer D., Panek D., Kramer H.J., Lindemann M., Kitahara M., Boor P., Kerjaschki D., Trzaskos J.M., Floege J., Ostendorf T. In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 2002, 13:1473-1480.
11. Bonner J.C. Regulation of platelet-derived growth factor (PDGF) and alveolar macrophage-derived PDGF by alpha 2-macroglobulin. Ann. N. Y. Acad. Sci. 1994, 737:324-338.
12. Bowman T., Broome M.A., Sinibaldi D., Wharton W., Pledger W.J., Sedivy J.M., Irby R., Yeatman T., Courtneidge S.A., Jove R. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7319-7324.
13. Bradshaw A.D., Francki A., Motamed K., Howe C., Sage E.H. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol. Biol. Cell 1999, 10:1569-1579.
14. Burger A., Wagner C., Viedt C., Reis B., Hug F., Hansch G.M. Fibronectin synthesis by human tubular epithelial cells in culture: effects of PDGF and TGF-beta on synthesis and splicing. Kidney Int. 1998, 54:407-415.
15. Chandra A., Angle N. VEGF inhibits PDGF-stimulated calcium signaling independent of phospholipase C and protein kinase C. J. Surg. Res. 2006, 131:302-309.
16. Changsirikulchai S., Hudkins K.L., Goodpaster T.A., Volpone J., Topouzis S., Gilbertson D.G., Alpers C.E. Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int. 2002, 62:2043-2054.
17. Chen Y.M., Hu-Tsai M.I., Lin S.L., Tsai T.J., Hsieh B.S. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats. Nephrol. Dial. Transplant. 2003, 18:2505-2514.
18. Chiara F., Bishayee S., Heldin C.H., Demoulin J.B. Autoinhibition of the platelet-derived growth factor beta-receptor tyrosine kinase by its C-terminal tail. J. Biol. Chem. 2004, 279:19732-19738.
19. Choudhury G.G., Grandaliano G., Jin D.C., Katz M.S., Abboud H.E. Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. Kidney Int. 2000, 57:908-917.
20. Choudhury G.G., Marra F., Kiyomoto H., Abboud H.E. PDGF stimulates tyrosine phosphorylation of JAK 1 protein tyrosine kinase in human mesangial cells. Kidney Int. 1996, 49:19-25.
21. Dixon B.S., Evanoff D., Fang W.B., Dennis M.J. Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1. Am. J. Physiol. Cell Physiol. 2002, 283:C193-C203.
22. Doi T., Vlassara H., Kirstein M., Yamada Y., Striker G.E., Striker L.J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:2873-2877.
23. Eitner F., Bucher E., van Roeyen C., Kunter U., Rong S., Seikrit C., Villa L., Boor P., Fredriksson L., Backstrom G., Eriksson U., Ostman A., Floege J., Ostendorf T. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J. Am. Soc. Nephrol. 2008, 19:281-289.
24. Eitner F., Ostendorf T., Kretzler M., Cohen C.D., Eriksson U., Grone H.J., Floege J. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J. Am. Soc. Nephrol. 2003, 14:1145-1153.
25. Eitner F., Ostendorf T., Van Roeyen C., Kitahara M., Li X., Aase K., Grone H.J., Eriksson U., Floege J. Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney. J. Am. Soc. Nephrol. 2002, 13:910-917.
26. Fang L., Yan Y., Komuves L.G., Yonkovich S., Sullivan C.M., Stringer B., Galbraith S., Lokker N.A., Hwang S.S., Nurden P., Phillips D.R., Giese N.A. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler. Thromb. Vasc. Biol. 2004, 24:787-792.
27. Floege J., Burns M.W., Alpers C.E., Yoshimura A., Pritzl P., Gordon K., Seifert R.A., Bowen-Pope D.F., Couser W.G., Johnson R.J. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 1992, 41:297-309.
28. Floege J., Eitner F., Alpers C.E. A new look at platelet-derived growth factor in renal disease. J. Am. Soc. Nephrol. 2008, 19:12-23.
29. Floege J., Hudkins K.L., Seifert R.A., Francki A., Bowen-Pope D.F., Alpers C.E. Localization of PDGF alpha-receptor in the developing and mature human kidney. Kidney Int. 1997, 51:1140-1150.
30. Floege J., Johnson R.J. Multiple roles for platelet-derived growth factor in renal disease. Miner. Electrolyte Metab. 1995, 21:271-282.
31. Floege J., Johnson R.J., Alpers C.E., Fatemi-Nainie S., Richardson C.A., Gordon K., Couser W.G. Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am. J. Pathol. 1993, 142:637-650.
32. Floege J., Topley N., Hoppe J., Barrett T.B., Resch K. Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines. Clin. Exp. Immunol. 1991, 86:334-341.
33. Francki A., Sage E.H. SPARC and the kidney glomerulus: matricellular proteins exhibit diverse functions under normal and pathological conditions. Trends Cardiovasc. Med. 2001, 11:32-37.
34. Fraser D., Brunskill N., Ito T., Phillips A. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-beta 1 synthesis via an autocrine PDGF loop. Am. J. Pathol. 2003, 163:2565-2574.
35. Fredriksson L., Ehnman M., Fieber C., Eriksson U. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator. J. Biol. Chem. 2005, 280:26856-26862.
36. Fujigaki Y., Sun D.F., Fujimoto T., Suzuki T., Goto T., Yonemura K., Morioka T., Yaoita E., Hishida A. Mechanisms and kinetics of Bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents. Nephron 2002, 92:203-212.
37. Gesualdo L., Di Paolo S., Milani S., Pinzani M., Grappone C., Ranieri E., Pannarale G., Schena F.P. Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J. Clin. Invest. 1994, 94:50-58.
38. Gesualdo L., Pinzani M., Floriano J.J., Hassan M.O., Nagy N.U., Schena F.P., Emancipator S.N., Abboud H.E. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab. Invest. 1991, 65:160-167.
39. Ghanem M., Nijman R., Safan M., van der Kwast T., Vansteenbrugge G. Expression and prognostic value of platelet-derived growth factor-AA and its receptor alpha in nephroblastoma. BJU Int. 2010, 106:1389-1393.
40. Ghosh Choudhury G., Kim Y.S., Simon M., Wozney J., Harris S., Ghosh-Choudhury N., Abboud H.E. Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells. Involvement of mitogen-activated protein kinase. J. Biol. Chem. 1999, 274:10897-10902.
41. Goppelt-Struebe M., Fickel S., Reiser C.O. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells. Biochem. J. 2000, 345(Pt 2):217-224.
42. Hansch G.M., Wagner C., Burger A., Dong W., Staehler G., Stoeck M. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J. Cell. Physiol. 1995, 163:451-457.
43. He S., Kumar S.R., Zhou P., Krasnoperov V., Ryan S.J., Gill P.S., Hinton D.R. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest. Ophthalmol. Vis. Sci. 2010, 51:543-552.
44. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
45. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
46. Hung L.M., Tsai C.H., Chen J.K. TGF-beta1 selectively suppresses PDGF receptor signaling pathways in MG-63 human osteosarcoma cell. Life Sci. 1997, 61:685-693.
47. Iida H., Seifert R., Alpers C.E., Gronwald R.G., Phillips P.E., Pritzl P., Gordon K., Gown A.M., Ross R., Bowen-Pope D.F., Johnson R.J. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:6560-6564.
48. Ishizaka N., Matsuzaki G., Saito K., Noiri E., Mori I., Nagai R. Expression and localization of PDGF-B, PDGF-D, and PDGF receptor in the kidney of angiotensin II-infused rat. Lab. Invest. 2006, 86:1285-1292.
49. Ishizawa K., Dorjsuren N., Izawa-Ishizawa Y., Sugimoto R., Ikeda Y., Kihira Y., Kawazoe K., Tomita S., Tsuchiya K., Minakuchi K., Tamaki T. Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration. J. Endocrinol. 2009, 202:309-316.
50. Johnson R.J., Alpers C.E., Yoshimura A., Lombardi D., Pritzl P., Floege J., Schwartz S.M. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992, 19:464-474.
51. Kanemoto K., Usui J., Tomari S., Yokoi H., Mukoyama M., Aten J., Weening J.J., Nagata M. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab. Invest. 2003, 83:1615-1625.
52. Kawano H., Kim S., Ohta K., Nakao T., Miyazaki H., Nakatani T., Iwao H. Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression. J. Am. Soc. Nephrol. 2003, 14:584-592.
53. Kazlauskas A., Cooper J.A. Phosphorylation of the PDGF receptor beta subunit creates a tight binding site for phosphatidylinositol 3 kinase. EMBO J. 1990, 9:3279-3286.
54. Kim H.K., Kim J.W., Zilberstein A., Margolis B., Kim J.G., Schlessinger J., Rhee S.G. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell 1991, 65:435-441.
55. Kimura M., Asano M., Abe K., Miyazaki M., Suzuki T., Hishida A. Role of atrophic changes in proximal tubular cells in the peritubular deposition of type IV collagen in a rat renal ablation model. Nephrol. Dial. Transplant. 2005, 20:1559-1565.
56. Kliem V., Johnson R.J., Alpers C.E., Yoshimura A., Couser W.G., Koch K.M., Floege J. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int. 1996, 49:666-678.
57. Klinghoffer R.A., Duckworth B., Valius M., Cantley L., Kazlauskas A. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity. Mol. Cell. Biol. 1996, 16:5905-5914.
58. Klinghoffer R.A., Mueting-Nelsen P.F., Faerman A., Shani M., Soriano P. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol. Cell 2001, 7:343-354.
59. Kong D., Li Y., Wang Z., Banerjee S., Ahmad A., Kim H.R., Sarkar F.H. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009, 27:1712-1721.
60. Kunz D., Walker G., Eberhardt W., Messmer U.K., Huwiler A., Pfeilschifter J. Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. J. Clin. Invest. 1997, 100:2800-2809.
61. LaRochelle W.J., Jeffers M., McDonald W.F., Chillakuru R.A., Giese N.A., Lokker N.A., Sullivan C., Boldog F.L., Yang M., Vernet C., Burgess C.E., Fernandes E., Deegler L.L., Rittman B., Shimkets J., Shimkets R.A., Rothberg J.M., Lichenstein H.S. PDGF-D, a new protease-activated growth factor. Nat. Cell Biol. 2001, 3:517-521.
62. Lei J., Silbiger S., Ziyadeh F.N., Neugarten J. Serum-stimulated alpha 1 type IV collagen gene transcription is mediated by TGF-beta and inhibited by estradiol. Am. J. Physiol. 1998, 274:F252-F258.
63. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994, 8:1875-1887.
64. Li X., Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev. 2003, 14:91-98.
65. Li X., Ponten A., Aase K., Karlsson L., Abramsson A., Uutela M., Backstrom G., Hellstrom M., Bostrom H., Li H., Soriano P., Betsholtz C., Heldin C.H., Alitalo K., Ostman A., Eriksson U. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat. Cell Biol. 2000, 2:302-309.
66. Liapis H., Nag M., Steinhardt G. Effects of experimental ureteral obstruction on platelet-derived growth factor-A and type I procollagen expression in fetal metanephric kidneys. Pediatr. Nephrol. 1994, 8:548-554.
67. Lindahl P., Hellstrom M., Kalen M., Karlsson L., Pekny M., Pekna M., Soriano P., Betsholtz C. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998, 125:3313-3322.
68. Liu G., Changsirikulchai S., Hudkins K.L., Banas M.C., Kowalewska J., Yang X., Wietecha T.A., Volpone J., Gilbertson D.G., Alpers C.E. Identification of platelet-derived growth factor D in human chronic allograft nephropathy. Hum. Pathol. 2008, 39:393-402.
69. Mahimainathan L., Choudhury G.G. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J. Biol. Chem. 2004, 279:15258-15268.
70. Marx M., Daniel T.O., Kashgarian M., Madri J.A. Spatial organization of the extracellular matrix modulates the expression of PDGF-receptor subunits in mesangial cells. Kidney Int. 1993, 43:1027-1041.
71. Matsumoto K., Hiraiwa N., Yoshiki A., Ohnishi M., Kusakabe M. PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice. Biochem. Biophys. Res. Commun. 2002, 290:1220-1227.
72. McAllister B.S., Leeb-Lundberg F., Olson M.S. Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts. Am. J. Physiol. 1993, 265:C477-C484.
73. Mioh H., Chen J.K. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels. J. Cell. Physiol. 1989, 139:509-516.
74. Mitchell D., Rodgers K., Hanly J., McMahon B., Brady H.R., Martin F., Godson C. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am. J. Pathol. 2004, 164:937-946.
75. Muhlfeld A.S., Spencer M.W., Hudkins K.L., Kirk E., LeBoeuf R.C., Alpers C.E. Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice. Kidney Int. 2004, 66:1393-1402.
76. Nakagawa H., Sasahara M., Haneda M., Koya D., Hazama F., Kikkawa R. Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats. Diabetes Res. Clin. Pract. 2000, 48:87-98.
77. Nakagawa T., Sasahara M., Haneda M., Kataoka H., Nakagawa H., Yagi M., Kikkawa R., Hazama F. Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury. Am. J. Pathol. 1999, 155:1689-1699.
78. Nakamura T., Ebihara I., Fukui M., Osada S., Nagaoka I., Horikoshi S., Tomino Y., Koide H. Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis. Clin. Immunol. Immunopathol. 1993, 66:33-42.
79. Nakamura T., Fukui M., Ebihara I., Osada S., Nagaoka I., Tomino Y., Koide H. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993, 42:450-456.
80. Ostendorf T., Eitner F., Floege J. The PDGF family in renal fibrosis. Pediatr. Nephrol. 2011, [E-pub ahead of print]. 10.1007/s00467-011-1892-z.
81. Ostendorf T., van Roeyen C.R., Peterson J.D., Kunter U., Eitner F., Hamad A.J., Chan G., Jia X.C., Macaluso J., Gazit-Bornstein G., Keyt B.A., Lichenstein H.S., LaRochelle W.J., Floege J. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 2003, 14:2237-2247.
82. Paukku K., Valgeirsdottir S., Saharinen P., Bergman M., Heldin C.H., Silvennoinen O. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem. J. 2000, 345(Pt 3):759-766.
83. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol. Pathol. 2001, 54:57-79.
84. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:1281-1285.
85. Reigstad L.J., Varhaug J.E., Lillehaug J.R. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J. 2005, 272:5723-5741.
86. Ricono J.M., Arar M., Choudhury G.G., Abboud H.E. Effect of platelet-derived growth factor isoforms in rat metanephric mesenchymal cells. Am. J. Physiol. Renal Physiol. 2002, 282:F211-F219.
87. Rosenkranz S., DeMali K.A., Gelderloos J.A., Bazenet C., Kazlauskas A. Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis. J. Biol. Chem. 1999, 274:28335-28343.
88. Sano H., Ueda Y., Takakura N., Takemura G., Doi T., Kataoka H., Murayama T., Xu Y., Sudo T., Nishikawa S., Nishikawa S., Fujiwara H., Kita T., Yokode M. Blockade of platelet-derived growth factor receptor-beta pathway induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am. J. Pathol. 2002, 161:135-143.
89. Seifert R.A., Alpers C.E., Bowen-Pope D.F. Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney. Kidney Int. 1998, 54:731-746.
90. Shankland S.J., Floege J., Thomas S.E., Nangaku M., Hugo C., Pippin J., Henne K., Hockenberry D.M., Johnson R.J., Couser W.G. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int. 1997, 52:404-413.
91. Shankland S.J., Ly H., Thai K., Scholey J.W. Increased glomerular capillary pressure alters glomerular cytokine expression. Circ. Res. 1994, 75:844-853.
92. Shehata M., el Nahas A., Barkworth E., Cope G.H., Raftery A.T. Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats. Kidney Int. 1994, 46:726-732.
93. Shibamiya A., Muhl L., Tannert-Otto S., Preissner K.T., Kanse S.M. Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation. Biochem. J. 2007, 404:45-50.
94. Sicheri F., Kuriyan J. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 1997, 7:777-785.
95. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994, 8:1888-1896.
96. Tallquist M., Kazlauskas A. PDGF signaling in cells and mice. Cytokine Growth Factor Rev. 2004, 15:205-213.
97. Tanaka R., Sugihara K., Tatematsu A., Fogo A. Internephron heterogeneity of growth factors and sclerosis - modulation of platelet-derived growth factor by angiotensin II. Kidney Int. 1995, 47:131-139.
98. Taneda S., Hudkins K.L., Cui Y., Farr A.G., Alpers C.E., Segerer S. Growth factor expression in a murine model of cryoglobulinemia. Kidney Int. 2003, 63:576-590.
99. Taneda S., Hudkins K.L., Topouzis S., Gilbertson D.G., Ophascharoensuk V., Truong L., Johnson R.J., Alpers C.E. Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J. Am. Soc. Nephrol. 2003, 14:2544-2555.
100. Throckmorton D.C., Brogden A.P., Min B., Rasmussen H., Kashgarian M. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int. 1995, 48:111-117.
101. Ustach C.V., Huang W., Conley-LaComb M.K., Lin C.Y., Che M., Abrams J., Kim H.R. A novel signaling axis of matriptase/PDGF-D/ss-PDGFR in human prostate cancer. Cancer Res. 2010, 70:9631-9640.
102. Valius M., Bazenet C., Kazlauskas A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 1993, 13:133-143.
103. van Roeyen C.R., Eitner F., Martinkus S., Thieltges S.R., Ostendorf T., Bokemeyer D., Luscher B., Luscher-Firzlaff J.M., Floege J., Mertens P.R. Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J. Am. Soc. Nephrol. 2005, 16:2985-2996.
104. van Roeyen C.R., Eitner F., Scholl T., Boor P., Kunter U., Planque N., Grone H.J., Bleau A.M., Perbal B., Ostendorf T., Floege J. CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. Kidney Int. 2008, 73:86-94.
105. van Roeyen C.R., Ostendorf T., Denecke B., Bokemeyer D., Behrmann I., Strutz F., Lichenstein H.S., LaRochelle W.J., Pena C.E., Chaudhuri A., Floege J. Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells. Kidney Int. 2006, 69:1393-1402.
106. Wallmon A., Fellstrom B., Larsson R., Floege J., Topley N., Ljunghall S. PDGF-BB, but not PDGF-AA, stimulates calcium mobilization, activation of calcium channels and cell proliferation in cultured rat mesangial cells. Exp. Nephrol. 1993, 1:238-244.
107. Yamabe H., Osawa H., Kaizuka M., Tsunoda S., Shirato K., Tateyama F., Okumura K. Platelet-derived growth factor, basic fibroblast growth factor, and interferon gamma increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-beta-dependent mechanism. Nephrol. Dial. Transplant. 2000, 15:872-876.
108. Yokote K., Hellman U., Ekman S., Saito Y., Ronnstrand L., Heldin C.H., Mori S. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins. Oncogene 1998, 16:1229-1239.
109. Yoshimura A., Gordon K., Alpers C.E., Floege J., Pritzl P., Ross R., Couser W.G., Bowen-Pope D.F., Johnson R.J. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 1991, 40:470-476.
110. Young B.A., Johnson R.J., Alpers C.E., Eng E., Gordon K., Floege J., Couser W.G., Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 1995, 47:935-944.